The CHARM programme.
Pechlaner
Christoph
C
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents / Q000191:economics / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000191:economics / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D002423:Cause of Death; D006333:Heart Failure / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D006801:Humans; D009017:Morbidity; D012306:Risk; D013777:Tetrazoles / Q000191:economics / Q000627:therapeutic use*; D016896:Treatment Outcome
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; C081643:candesartan